Introduction Several different forms of automated insulin delivery systems (AID systems)
have recently been developed and are now licensed for type 1 diabetes (T1D). We …

Automated insulin delivery (AID) systems, so-called closed-loop systems or artificial
pancreas, are based upon the concept of insulin supply driven by blood glucose levels and …

Background: The t: slim X2™ insulin pump with Control-IQ® technology from Tandem
Diabetes Care is an advanced hybrid closed-loop system that was first commercialized in …

Background Automated insulin delivery aims to lower treatment burden and improve quality
of life as well as glycemic outcomes. Methods We present sub-study data from a dual-center …

Background: Studies of closed-loop control (CLC) in patients with type 1 diabetes (T1D)
consistently demonstrate improvements in glycemic control as measured by increased time …

Background Time in range (TIR) goals are rarely met in children with type 1 diabetes, except
at the cost of increased hypoglycaemia episodes. Our objective was to evaluate the safety …

Human and experimental animal data suggest both hyperglycemia and hypoglycemia can
lead to altered brain structure and neurocognitive function in type 1 diabetes (T1D). Young …

Aims Insulin administration is the treatment of choice for people with type 1 diabetes mellitus
(T1D). Technological advances have led to the development of automated insulin delivery …

Introduction: Hybrid closed-loop systems increase time-in-range (TIR) and reduce glycemic
variability. Person-reported outcomes (PROs) are essential to assess the utility of new …

Background The greatest change in the treatment of people living with type 1 diabetes in the
last decade has been the explosion of technology assisting in all aspects of diabetes …